Novartis U.S. pharmaceuticals head will be Astra Merck CEO Yetter.
NOVARTIS U.S. PHARMA BUSINESS WILL BE HEADED BY ex-ASTRA MERCK CEO YETTER, who will assume leadership of the pharmaceuticals business of the newly merged Ciba and Sandoz on Feb. 1. Novartis Pharmaceuticals Corp. USA is headquartered in East Hanover, N.J. Wayne Yetter will report to worldwide pharmaceuticals sector head Pierre Douaze. Former Ciba exec Douglas Watson is CEO of Novartis U.S.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth